Please assist with answering (numbers 4-6)

Over a decade ago The New England Journal of Medicine proposed that all articles published on new therapies should close with a cost/benefit analysis comparing its benefits and costs against the best selling alternative therapy. This initiative was squashed by the pharmaceutical industry that also used lobbying to prevent the Federal Drug Administration from requiring performance tests against the best-selling alternative rather than no treatment at all (a placebo). Today, it looks like the industry is finally caving to pressure to require such testing, and that this testing must form the basis for performance and quality claims in the marketing of the new drug. The following information is the result of a test of PreventInfect, a drug developed to help prevent infections in cancer patients whose immune systems have been weakened by chemotherapy: PreventInfect Metrics Probability of getting an infection without any treatment (po) 0.4 Probability of getting an infection with current best treatment (pcb) 0.2 Probability of getting an infection with PreventInfect treatment (pPI) 0.1 Average cost of treatment of infection without any treatment ($Io) $15,000 Average cost of treatment of infection with current best treatment ($Icb) $12,000 Average cost of treatment of infection with PreventInfect treatment ($IPI) $5,000 Cost of current best treatment ($Tcb) $1,200 Cost of PreventInfect treatment ($TPI) $2,000

4.) Does excluding the cost to the hospital of being sued for infecting a cancer patient who then dies understate or overstate the benefits and quality-added of PreventInfect?

5.) Should the pain and suffering of patients who get an infection be considered when selling the use of PreventInfect to the patients family?

6.) Should the pain and suffering of patients who get an infection be considered when selling the use of PreventInfect to the hospital? If you say no then this implies you believe the hospitals are not as customer caring as they claim to be in all their advertising. If you say yes then this implies you believe the hospitals do genuinely care about their customers pain and suffering. So would you?